Dr. Joseph C Masdeu, MD, PhD
Claim this profileHouston Methodist Neurological Institute
Studies Cognitive Impairment
Studies Dementia
7 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Joseph C Masdeu, MD, PhD is currently running
Study
for Early-Onset Alzheimer's Disease
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals with early onset cognitive impairment. Clinical, cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EOnonAD) participants, and (3) cognitively normal (CN) control participants.
Recruiting1 award N/A10 criteria
Verdiperstat
for Frontotemporal Dementia
This trial tests the safety of Verdiperstat, a medication taken regularly, in patients with language difficulties caused by brain issues. The study aims to see if the drug can change protein levels in the brain and improve cognitive functions.
Recruiting0 awards Phase 111 criteria
More about Joseph C Masdeu, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Joseph C Masdeu, MD, PhD has experience with
- Ocrelizumab
- Donanemab
- Nicotine Transdermal Patch
- Placebo Patch
- Florbetaben
- Flortaucipir
Breakdown of trials Joseph C Masdeu, MD, PhD has run
Cognitive Impairment
Dementia
Alzheimer's disease
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph C Masdeu, MD, PhD specialize in?
Joseph C Masdeu, MD, PhD focuses on Cognitive Impairment and Dementia. In particular, much of their work with Cognitive Impairment has involved treating patients, or patients who are undergoing treatment.
Is Joseph C Masdeu, MD, PhD currently recruiting for clinical trials?
Yes, Joseph C Masdeu, MD, PhD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Joseph C Masdeu, MD, PhD has studied deeply?
Yes, Joseph C Masdeu, MD, PhD has studied treatments such as Ocrelizumab, Donanemab, Nicotine Transdermal Patch.
What is the best way to schedule an appointment with Joseph C Masdeu, MD, PhD?
Apply for one of the trials that Joseph C Masdeu, MD, PhD is conducting.
What is the office address of Joseph C Masdeu, MD, PhD?
The office of Joseph C Masdeu, MD, PhD is located at: Houston Methodist Neurological Institute, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Neurological Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.